Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population.

Wu Z, Jiang H, Zhang L, Xu X, Zhang X, Kang Z, Song D, Zhang J, Guan M, Gu Y.

PLoS One. 2012;7(10):e48179. doi: 10.1371/journal.pone.0048179. Epub 2012 Oct 23.

PMID:
23110205
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.

Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A, Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M, Miyamoto S, Nagata K, Hashimoto N, Koizumi A.

PLoS One. 2011;6(7):e22542. doi: 10.1371/journal.pone.0022542. Epub 2011 Jul 20.

PMID:
21799892
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations.

Liu W, Hitomi T, Kobayashi H, Harada KH, Koizumi A.

Neurol Med Chir (Tokyo). 2012;52(5):299-303.

PMID:
22688066
[PubMed - indexed for MEDLINE]
Free Article
4.

Impacts and interactions of PDGFRB, MMP-3, TIMP-2, and RNF213 polymorphisms on the risk of Moyamoya disease in Han Chinese human subjects.

Wang X, Zhang Z, Liu W, Xiong Y, Sun W, Huang X, Jiang Y, Ni G, Sun W, Zhou L, Wu L, Zhu W, Li H, Liu X, Xu G.

Gene. 2013 Sep 10;526(2):437-42. doi: 10.1016/j.gene.2013.05.083. Epub 2013 Jun 12.

PMID:
23769926
[PubMed - indexed for MEDLINE]
5.

A genome-wide association study identifies RNF213 as the first Moyamoya disease gene.

Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N, Owada Y, Fujimura M, Mashimo Y, Suzuki Y, Hata A, Tsuchiya S, Tominaga T, Matsubara Y, Kure S.

J Hum Genet. 2011 Jan;56(1):34-40. doi: 10.1038/jhg.2010.132. Epub 2010 Nov 4.

PMID:
21048783
[PubMed - indexed for MEDLINE]
6.

The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality.

Hitomi T, Habu T, Kobayashi H, Okuda H, Harada KH, Osafune K, Taura D, Sone M, Asaka I, Ameku T, Watanabe A, Kasahara T, Sudo T, Shiota F, Hashikata H, Takagi Y, Morito D, Miyamoto S, Nakao K, Koizumi A.

Biochem Biophys Res Commun. 2013 Oct 4;439(4):419-26. doi: 10.1016/j.bbrc.2013.08.067. Epub 2013 Aug 27.

PMID:
23994138
[PubMed - indexed for MEDLINE]
7.

Identification of a genetic variant common to moyamoya disease and intracranial major artery stenosis/occlusion.

Miyawaki S, Imai H, Takayanagi S, Mukasa A, Nakatomi H, Saito N.

Stroke. 2012 Dec;43(12):3371-4. doi: 10.1161/STROKEAHA.112.663864. Epub 2012 Sep 25. Erratum in: Stroke. 2012 Dec;43(12):e182.

PMID:
23010677
[PubMed - indexed for MEDLINE]
Free Article
8.

Genetic variant RNF213 c.14576G>A in various phenotypes of intracranial major artery stenosis/occlusion.

Miyawaki S, Imai H, Shimizu M, Yagi S, Ono H, Mukasa A, Nakatomi H, Shimizu T, Saito N.

Stroke. 2013 Oct;44(10):2894-7. doi: 10.1161/STROKEAHA.113.002477. Epub 2013 Aug 22.

PMID:
23970789
[PubMed - indexed for MEDLINE]
9.

Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients.

Hitomi T, Habu T, Kobayashi H, Okuda H, Harada KH, Osafune K, Taura D, Sone M, Asaka I, Ameku T, Watanabe A, Kasahara T, Sudo T, Shiota F, Hashikata H, Takagi Y, Morito D, Miyamoto S, Nakao K, Koizumi A.

Biochem Biophys Res Commun. 2013 Aug 16;438(1):13-9. doi: 10.1016/j.bbrc.2013.07.004. Epub 2013 Jul 12.

PMID:
23850618
[PubMed - indexed for MEDLINE]
10.

Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease.

Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, Tsurusaki Y, Doi H, Sakai H, Saitsu H, Shimojima K, Yamamoto T, Higurashi M, Kawahara N, Kawauchi H, Nagasaka K, Okamoto N, Mori T, Koyano S, Kuroiwa Y, Taguri M, Morita S, Matsubara Y, Kure S, Matsumoto N.

Neurology. 2012 Mar 13;78(11):803-10. doi: 10.1212/WNL.0b013e318249f71f. Epub 2012 Feb 29.

PMID:
22377813
[PubMed - indexed for MEDLINE]
11.

P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure.

Koizumi A, Kobayashi H, Liu W, Fujii Y, Senevirathna ST, Nanayakkara S, Okuda H, Hitomi T, Harada KH, Takenaka K, Watanabe T, Shimbo S.

Environ Health Prev Med. 2013 Mar;18(2):121-9. doi: 10.1007/s12199-012-0299-1. Epub 2012 Aug 10.

PMID:
22878964
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

RNF213 polymorphism and Moyamoya disease: A systematic review and meta-analysis.

Ma J, Liu Y, Ma L, Huang S, Li H, You C.

Neurol India. 2013 Jan-Feb;61(1):35-9. doi: 10.4103/0028-3886.107927.

PMID:
23466837
[PubMed - in process]
Free Article
13.

Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G>A variant in RNF213 showed varying clinical course and severity.

Miyatake S, Touho H, Miyake N, Ohba C, Doi H, Saitsu H, Taguri M, Morita S, Matsumoto N.

J Hum Genet. 2012 Dec;57(12):804-6. doi: 10.1038/jhg.2012.105. Epub 2012 Aug 30.

PMID:
22931863
[PubMed - indexed for MEDLINE]
14.

Association of a functional polymorphism in the MMP-3 gene with Moyamoya Disease in the Chinese Han population.

Li H, Zhang ZS, Liu W, Yang WZ, Dong ZN, Ma MJ, Han C, Yang H, Cao WC, Duan L.

Cerebrovasc Dis. 2010;30(6):618-25. doi: 10.1159/000319893. Epub 2010 Oct 15.

PMID:
20948207
[PubMed - indexed for MEDLINE]
15.

Ablation of Rnf213 retards progression of diabetes in the Akita mouse.

Kobayashi H, Yamazaki S, Takashima S, Liu W, Okuda H, Yan J, Fujii Y, Hitomi T, Harada KH, Habu T, Koizumi A.

Biochem Biophys Res Commun. 2013 Mar 15;432(3):519-25. doi: 10.1016/j.bbrc.2013.02.015. Epub 2013 Feb 11.

PMID:
23410753
[PubMed - indexed for MEDLINE]
16.

[Current knowledge on the genetic factors involved in moyamoya disease].

Hashikata H, Liu W, Mineharu Y, Inoue K, Takenaka K, Ikeda H, Houkin K, Kuroda S, Kikuchi K, Kimura M, Taki T, Sonobe M, Ban S, Nogaki H, Handa A, Kikuta K, Takagi Y, Nozaki K, Hashimoto N, Koizumi A.

Brain Nerve. 2008 Nov;60(11):1261-9. Review. Japanese.

PMID:
19069159
[PubMed - indexed for MEDLINE]
17.

Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: a susceptibility gene for moyamoya disease.

Sonobe S, Fujimura M, Niizuma K, Nishijima Y, Ito A, Shimizu H, Kikuchi A, Arai-Ichinoi N, Kure S, Tominaga T.

Brain Res. 2014 Mar 13;1552:64-71. doi: 10.1016/j.brainres.2014.01.011. Epub 2014 Jan 17.

PMID:
24440776
[PubMed - in process]
18.

Analysis of TGFB1 in European and Japanese Moyamoya disease patients.

Liu C, Roder C, Schulte C, Kasuya H, Akagawa H, Nishizawa T, Yoneyama T, Okada Y, Khan N, Tatagiba M, Berg D, Krischek B.

Eur J Med Genet. 2012 Oct;55(10):531-4. doi: 10.1016/j.ejmg.2012.05.002. Epub 2012 Jun 1.

PMID:
22659181
[PubMed - indexed for MEDLINE]
19.

Familial occurrence of moyamoya disease: a clinical study.

Seol HJ, Wang KC, Kim SK, Hwang YS, Kim KJ, Cho BK.

Childs Nerv Syst. 2006 Sep;22(9):1143-8. Epub 2006 Mar 25.

PMID:
16565850
[PubMed - indexed for MEDLINE]
20.

Rapid progression of unilateral moyamoya disease in a patient with a family history and an RNF213 risk variant.

Mineharu Y, Takagi Y, Takahashi JC, Hashikata H, Liu W, Hitomi T, Kobayashi H, Koizumi A, Miyamoto S.

Cerebrovasc Dis. 2013;36(2):155-7. doi: 10.1159/000352065. Epub 2013 Sep 11. No abstract available.

PMID:
24029639
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk